Lyell Immunopharma (LYEL) Institutional Ownership $10.58 -0.18 (-1.67%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$10.57 -0.01 (-0.09%) As of 08/15/2025 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lyell Immunopharma (NASDAQ:LYEL)CurrentInstitutional OwnershipPercentage66.05%Number ofInstitutional Buyers(last 12 months)41TotalInstitutional Inflows(last 12 months)$531.47MNumber ofInstitutional Sellers(last 12 months)36TotalInstitutional Outflows(last 12 months)$895.77M Get LYEL Insider Trade Alerts Want to know when executives and insiders are buying or selling Lyell Immunopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LYEL Institutional Buying and Selling by Quarter Lyell Immunopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Orland Properties Ltd754,698$6.67M2.8%-95.0%3.929% 8/15/2025 MWG Management Ltd.1,008,116$8.91M17.2%-95.0%5.248% 8/15/2025 HSG Holding Ltd152,299$1.35M0.1%-95.0%0.793% 8/15/2025 Boothbay Fund Management LLC12,234$108K0.0%-95.0%0.064% 8/15/2025 Bridgeway Capital Management LLC18,000$159K0.0%N/A0.094% 8/15/2025 Bank of America Corp DE23,758$210K0.0%-74.7%0.124% 8/15/2025 ARCH Venture Management LLC1,820,634$16.11M5.4%N/A9.478% 8/14/2025 Orbimed Advisors LLC51,727$457K0.0%N/A0.335% 8/14/2025 Raymond James Financial Inc.7,900$70K0.0%-95.0%0.051% 8/14/2025 Canada Pension Plan Investment Board29,411$260K0.0%-95.0%0.190% Get the Latest News and Ratings for LYEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lyell Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 8/14/2025 The Manufacturers Life Insurance Company 24,419$216K0.0%-95.2%0.158% 8/14/2025 RBF Capital LLC100,000$884K0.0%N/A0.647% 8/13/2025 Marshall Wace LLP10,580$94K0.0%N/A0.068% 8/13/2025 Walleye Capital LLC29,230$258K0.0%N/A0.189% 8/13/2025 Decheng Capital LLC595,466$5.26M1.2%-95.0%3.852% 8/13/2025 Invesco Ltd.12,809$113K0.0%-96.6%0.083% 8/12/2025 Foresite Capital Management V LLC406,652$3.60M4.5%-95.0%2.630% 8/12/2025 Foresite Capital Management IV LLC800,399$7.08M5.7%-95.0%5.177% 8/12/2025 JPMorgan Chase & Co.3,369$30K0.0%-98.3%0.022% 8/8/2025 Geode Capital Management LLC103,270$913K0.0%-97.7%0.668% 8/8/2025 Takeda Pharmaceutical Co. Ltd.41,165$364K1.9%-95.0%0.266% 8/1/2025 Alphabet Inc.293,256$2.59M0.1%-95.0%1.980% 7/28/2025 TD Asset Management Inc50,232$444K0.0%-95.0%0.339% 7/22/2025 Johnson & Johnson41,165$368K0.1%-95.0%0.278% 7/22/2025 Clarius Group LLC19,138$169K0.0%-95.2%0.129% 6/27/2025 Goldman Sachs Group Inc.358,592$193K0.0%-42.8%2.421% 6/18/2025 Voya Investment Management LLC50,329$27K0.0%-4.9%0.340% 5/29/2025 Rhumbline Advisers235,694$127K0.0%-16.2%0.080% 5/21/2025 Acadian Asset Management LLC660,899$354K0.0%+204.2%0.224% 5/19/2025 Jane Street Group LLC64,241$35K0.0%-73.2%0.022% 5/16/2025 Goldman Sachs Group Inc.358,592$193K0.0%-42.8%0.121% 5/16/2025 Jacobs Levy Equity Management Inc.558,979$301K0.0%-59.6%0.189% 5/16/2025 AQR Capital Management LLC174,279$94K0.0%+773.5%0.059% 5/16/2025 Almitas Capital LLC2,482,606$1.34M0.4%+136.3%0.841% 5/12/2025 Nuveen LLC641,173$345K0.0%N/A0.217% 5/12/2025 Invesco Ltd.378,880$204K0.0%-7.0%0.128% 5/9/2025 Charles Schwab Investment Management Inc.1,604,676$863K0.0%-2.5%0.543% 4/17/2025 Exchange Traded Concepts LLC246,349$133K0.0%+82.4%0.083% 4/8/2025 Rhumbline Advisers235,694$127K0.0%-16.2%0.080% 2/19/2025 Public Employees Retirement System of Ohio99,307$64K0.0%N/A0.034% Utah’s New Oil Find (Ad)The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.Find out why this could be the most lucrative "underground" energy story in America2/17/2025 venBio Partners LLC7,102,190$4.55M2.7%N/A2.431% 2/17/2025 Two Sigma Investments LP204,501$131K0.0%-15.4%0.070% 2/17/2025 Two Sigma Advisers LP306,400$196K0.0%+143.8%0.105% 2/17/2025Nuveen Asset Management LLC641,173$410K0.0%-25.1%0.219% 2/17/2025 Orbimed Advisors LLC3,103,623$1.99M0.0%-49.0%1.062% 2/17/2025 Millennium Management LLC957,507$613K0.0%+34.8%0.328% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.308,551$197K0.0%+13.4%0.106% 2/17/2025 Jacobs Levy Equity Management Inc.1,385,301$887K0.0%N/A0.474% 2/17/2025 Graham Capital Management L.P.52,136$33K0.0%N/A0.018% 2/17/2025 Foresite Capital Management V LLC8,133,047$5.21M4.3%N/A2.784% 2/17/2025 D. E. Shaw & Co. Inc.966,265$618K0.0%+104.4%0.331% 2/17/2025 BNP Paribas Financial Markets253,669$162K0.0%N/A0.087% 2/17/2025 Almitas Capital LLC1,050,520$672K0.1%N/A0.360% 2/14/2025 Jane Street Group LLC239,439$153K0.0%-16.8%0.082% 2/14/2025 Northern Trust Corp1,310,224$839K0.0%-3.4%0.448% 2/14/2025 Decheng Capital LLC11,909,341$7.62M1.6%N/A4.076% 2/14/2025 Boothbay Fund Management LLC406,234$260K0.0%+190.4%0.139% 2/14/2025 Price T Rowe Associates Inc. MD6,910,749$4.42M0.0%-6.0%2.365% 2/14/2025 Johnson & Johnson823,317$527K0.1%N/A0.282% 2/13/2025 Barclays PLC258,380$165K0.0%+7.4%0.088% 2/13/2025 Renaissance Technologies LLC1,612,146$1.03M0.0%+716.7%0.552% 2/13/2025 Wells Fargo & Company MN94,320$60K0.0%+27.8%0.032% 2/12/2025 RPO LLC66,378$42K0.0%N/A0.023% 2/12/2025 Geode Capital Management LLC4,137,264$2.65M0.0%+2.9%1.416% 2/12/2025 Takeda Pharmaceutical Co. Ltd.823,317$527K2.0%N/A0.282% 2/12/2025 JPMorgan Chase & Co.433,265$277K0.0%+347.8%0.148% 2/11/2025 Prudential Financial Inc.48,057$31K0.0%-66.8%0.016% 2/6/2025 Charles Schwab Investment Management Inc.1,645,787$1.05M0.0%+43.4%0.563% 1/17/2025 SG Americas Securities LLC116,748$75K0.0%+102.8%0.040% 11/19/2024 Barclays PLC240,615$332K0.0%+312.7%0.082% 11/15/2024 Barclays PLC240,615$332K0.0%+312.7%0.086% 11/15/2024 Jane Street Group LLC287,717$397K0.0%+63.7%0.103% 11/15/2024 State Street Corp3,889,553$5.37M0.0%+1.9%1.393% 11/15/2024 Centiva Capital LP22,160$31K0.0%N/A0.008% 11/15/2024 Point72 Asia Singapore Pte. Ltd.37,704$52K0.0%N/A0.014% 11/15/2024 Erste Asset Management GmbH54,000$82K0.0%N/A0.019% 11/14/2024 MetLife Investment Management LLC36,287$50K0.0%-57.5%0.013% 11/13/2024 FMR LLC1,024,583$1.41M0.0%-62.5%0.367% 11/12/2024 Charles Schwab Investment Management Inc.1,147,370$1.58M0.0%-11.6%0.448% 11/9/2024 Intech Investment Management LLC37,495$52K0.0%N/A0.015% 11/8/2024WuXi AppTec Co. Ltd.7,390,710$10.20M53.6%-3.8%2.887% 11/6/2024 Cornercap Investment Counsel Inc.47,763$66K0.0%-50.4%0.019% 11/5/2024 Baillie Gifford & Co.141,949$196K0.0%-72.7%0.055% 11/5/2024 GSA Capital Partners LLP354,815$490K0.0%+1,285.5%0.139% 10/25/2024China Universal Asset Management Co. Ltd.49,238$68K0.0%+64.4%0.019% 10/10/2024 Exchange Traded Concepts LLC135,050$186K0.0%+37.3%0.053% 10/3/2024 SG Americas Securities LLC57,566$79K0.0%+78.1%0.023% 8/15/2024 Susquehanna Fundamental Investments LLC128,203$186K0.0%+49.5%0.050% 8/15/2024 The Manufacturers Life Insurance Company553,163$802K0.0%+14.4%0.217% 8/14/2024 ProShare Advisors LLC38,982$57K0.0%-20.4%0.015% Genesis 14:13-17 [HIDDEN MEANING?] (Ad)A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthright” — a $150 trillion wealth vault that’s remained untouched for over a century. Jim Rickards believes President Trump is about to unleash it — and investors who move first could come out on top. The full story is now available.Watch the presentation on America’s hidden birthright8/12/2024 XTX Topco Ltd70,174$102K0.0%-36.6%0.028% 8/9/2024 Renaissance Technologies LLC152,300$221K0.0%-64.0%0.060% 8/9/2024 Dimensional Fund Advisors LP40,098$58K0.0%+197.8%0.016% 8/9/2024 Massachusetts Financial Services Co. MA577,319$837K0.0%-62.5%0.226% 8/8/2024 American Century Companies Inc.279,425$405K0.0%+18.1%0.110% 8/6/2024WuXi AppTec Co. Ltd.7,682,156$11.14M47.7%-6.1%3.013% 8/3/2024 TD Asset Management Inc1,004,642$1.46M0.0%+4.2%0.394% 8/1/2024 Rhumbline Advisers260,742$378K0.0%-6.3%0.102% 7/29/2024 Principal Financial Group Inc.26,510$38K0.0%-54.5%0.010% 7/26/2024 Bank of New York Mellon Corp671,966$974K0.0%+6.1%0.264% (Data available from 1/1/2016 forward) LYEL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LYEL shares? During the previous two years, 95 institutional investors and hedge funds held shares of Lyell Immunopharma. The most heavily invested institutionals were Vanguard Group Inc. ($29.86M), ARCH Venture Management LLC ($16.11M), WuXi AppTec Co. Ltd. ($10.20M), MWG Management Ltd. ($8.91M), Opaleye Management Inc. ($7.48M), Foresite Capital Management IV LLC ($7.08M), and Orland Properties Ltd ($6.67M).Learn more on Lyell Immunopharma's institutional investors. What percentage of Lyell Immunopharma's stock is owned by institutional investors? 66.05% of Lyell Immunopharma's stock is owned by institutional investors. Learn more on LYEL's institutional investor holdings. Which institutional investors have been buying Lyell Immunopharma's stock? Of the 64 institutional investors that purchased Lyell Immunopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Decheng Capital LLC ($11.91M), WuXi AppTec Co. Ltd. ($8.18M), Foresite Capital Management V LLC ($8.13M), venBio Partners LLC ($7.10M), Opaleye Management Inc. ($3.36M), Almitas Capital LLC ($2.48M), and ARCH Venture Management LLC ($1.82M). How much institutional buying is happening at Lyell Immunopharma? Institutional investors have bought a total of 41,309,945 shares in the last 24 months. This purchase volume represents approximately $531.47M in transactions. Which of Lyell Immunopharma's major shareholders have been selling company stock? Of the 36 institutional investors that sold Lyell Immunopharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: MWG Management Ltd. ($19.15M), Foresite Capital Management IV LLC ($15.21M), Orland Properties Ltd ($14.34M), Decheng Capital LLC ($11.31M), Foresite Capital Management V LLC ($7.73M), Alphabet Inc. ($5.57M), and Geode Capital Management LLC ($4.30M). How much institutional selling is happening at Lyell Immunopharma? Institutional investors have sold a total of 93,655,837 shares in the last 24 months. This volume of shares sold represents approximately $895.77M in transactions. Related Companies NAGE Major Shareholders VIR Major Shareholders AMLX Major Shareholders ANAB Major Shareholders STOK Major Shareholders DNTH Major Shareholders DAWN Major Shareholders GHRS Major Shareholders AVBP Major Shareholders VALN Major Shareholders This page (NASDAQ:LYEL) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyell Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyell Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access